- Home
- SIG vs LGND Comparison
SIG vs LGND Comparison
Compare SIG & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SIG | LGND |
|---|---|---|
| Founded | 1950 | 1987 |
| Country | Bermuda | United States |
| Employees | N/A | 68 |
| Industry | Consumer Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.7B |
| IPO Year | 1997 | N/A |
Fundamental Metrics
Financial Performance| Metric | SIG | LGND |
|---|---|---|
| Price | $94.57 | $306.11 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | $111.14 | ★ $256.29 |
| AVG Volume (30 Days) | ★ 558.0K | 237.6K |
| Earning Date | 06-02-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.65% | N/A |
| EPS Growth | ★ 974.07 | N/A |
| EPS | ★ 0.78 | N/A |
| Revenue | ★ $6,247,100,000.00 | N/A |
| Revenue This Year | $1.39 | $1.25 |
| Revenue Next Year | $1.71 | $19.41 |
| P/E Ratio | $123.76 | ★ $76.27 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $71.62 | $137.14 |
| 52 Week High | $110.20 | $326.63 |
Technical Indicators
Market Signals| Indicator | SIG | LGND |
|---|---|---|
| Relative Strength Index (RSI) | N/A | N/A |
| Support Level | N/A | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
Price Performance
Historical ComparisonAbout SIG Signet Jewelers Limited
Signet Jewelers Ltd is a retailer of diamond jewelry. Its merchandise mix includes bridal, fashion, watches, and others. The bridal category includes engagement, wedding, and anniversary purchases. Its segments are the North America segment, the International segment, and the Other segment. The North America segment contributes to the majority of the revenue. The North America segment generates revenue from Mall and Outlet. Geographically, it operates in the USA, Canada, the UK, and Ireland, with the maximum revenue from the USA.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.